Literature DB >> 7565946

Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.

A D Goddard1, R Covello, S M Luoh, T Clackson, K M Attie, N Gesundheit, A C Rundle, J A Wells, L M Carlsson.   

Abstract

BACKGROUND: Short stature in children who are not deficient in growth hormone (GH) is probably caused by a variety of defects. Some children with idiopathic short stature have low serum concentrations of GH-binding protein, which is derived from the GH receptor. The possibility that low serum concentrations of GH-binding protein might indicate partial insensitivity to GH led us to investigate possible defects in the gene for the GH receptor in children with idiopathic short stature and low serum concentrations of GH-binding protein.
METHODS: We studied 14 children with idiopathic short stature who were selected on the basis of normal GH secretion and low serum concentrations of GH-binding protein. Analysis of single-strand conformation polymorphisms and DNA sequencing were both used to identify mutations in the GH-receptor gene.
RESULTS: Mutations in the region of the GH-receptor gene that codes for the extracellular domain of the receptor were found in 4 of the 14 children, but in none of 24 normal subjects. One of the four children with mutations was a compound heterozygote, with one mutation that reduced the affinity of the receptor for GH and a second mutation that may affect a function other than ligand binding. The remaining three children had single mutations in one allele of the gene. One mutation introduced a premature termination codon, and two caused substitutions of single amino acids in a structurally conserved domain of the receptor.
CONCLUSIONS: Some children with idiopathic short stature may have partial insensitivity to GH due to mutations in the GH-receptor gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565946     DOI: 10.1056/NEJM199510263331701

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

1.  Growth hormone insensitivity: a widening diagnosis.

Authors:  R Bjarnason; M O Savage
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

2.  Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Authors:  L A Metherell; S A Akker; P B Munroe; S J Rose; M Caulfield; M O Savage; S L Chew; A J Clark
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

Review 3.  Growth hormone therapy in children with short stature: is bigger better or achievable?

Authors:  J A Germak
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

4.  Clinical examples of disturbed IGF signaling: intrauterine and postnatal growth retardation due to mutations of the insulin-like growth factor I receptor (IGF-IR) gene.

Authors:  W Kiess; J Kratzsch; E Keller; A Schneider; K Raile; J Klammt; B Seidel; A Garten; H Schmidt; R Pfäffle
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

Review 5.  Advances in endocrinology.

Authors:  P E Clayton; V Tillmann
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

6.  Severe short stature and endogenous growth hormone resistance in twin brothers without growth hormone gene mutations.

Authors:  Emily C Walvoord; Kyle W Sloop; Conor J Dwyer; Simon J Rhodes; Ora H Pescovitz
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

7.  Identification of two novel mutations in the human growth hormone receptor gene.

Authors:  O Shevah; P Borrelli; M Rubinstein; Z Laron
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature.

Authors:  N Dávila; M Moreira-Andrés; J Alcañiz; B Barceló
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

Review 9.  Gene regulation by growth hormone.

Authors:  Peter Rotwein; Dennis J Chia
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

Review 10.  Treatment of dwarfism with recombinant human insulin-like growth factor-1.

Authors:  Michael B Ranke; Joachim Wölfle; Dirk Schnabel; Markus Bettendorf
Journal:  Dtsch Arztebl Int       Date:  2009-10-23       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.